Archives
In4Derm raises £1.6m pre-Series A funding to support its growing pipeline of first-in-class anti-inflammatory and orphan disease therapeutics 3 November, 2021
o2h Ventures “Human Health SEIS Fund” Invests into Sanome… 7 October, 2021
o2h Ventures portfolio company Small Pharma Successfully Completes Phase I Clinical Trial of DMT-assisted therapy 22 September, 2021
o2h Ventures backed Arecor enters into an exclusive formulation collaboration with Intas Pharmaceuticals 8 September, 2021
o2h Ventures backed In4Derm enters into an exclusive license agreement with VYNE Therapeutics 13 August, 2021
o2h Ventures ‘Knowledge Intensive Human Health EIS Fund’ invests into BiVictriX Therapeutics 5 August, 2021
Digital brain biomarker company Monument Therapeutics raises £2.6 million 20 July, 2021
o2h Ventures backed Arecor Granted Key US Patent 14 May, 2021
o2h Ventures backed Small Pharma Raises Cash to Fund Reverse Takeover on Toronto Stock Exchange 12 May, 2021